A detailed analysis of the murine TAP transporter substrate specificity

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Burgevin, Anne ^a,b   Saveanu, Loredana ^a,b   Kim, Yohan ^c   Barilleau, Émilie ^a,b   Kotturi, Maya ^c   Sette, Alessandro ^c   van Endert, Peter ^a,b   Peters, Bjoern ^c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEMBRANE PROTEIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; ABC TRANSPORTER; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING (TAP);

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME SPECIFICITY; EPITOPE MAPPING; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOGENICITY; MOUSE; NONHUMAN; PREDICTION; PROTEIN BINDING; QUANTITATIVE ANALYSIS; SPECIES DIFFERENCE; T LYMPHOCYTE; ANIMAL; ARMYWORM; METABOLISM;

MURINAE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; MICE; SPODOPTERA; SUBSTRATE SPECIFICITY; T-LYMPHOCYTES;

EID: 48749121228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002402     Document Type: Article

References (47)

1. Shastri N, Schwab S, Serwold T (2002) Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 20: 463-493.
2. Swain SL, Dutton RW, Woodland DL (2004) T cell responses to influenza virus infection: effector and memory cells. Viral Immunol 17: 197-209.
3. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, et al. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-117.
4. Bowen DG, Walker CM (2005) Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946-952.
5. Pamer EG (1994) Direct sequence identification and kinetic analysis or an MHC class I-restricted Listeria monocytogenes CTL epitope. J Immunol 152: 686-694.
6. Lalvani A, Brookes R, Wilkinson RJ, Malin AS, Pathan AA, et al. (1998) Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 95: 270-275.
7. Li Z, Diaz-Montero CM, Valbuena G, Yu XJ, Olano JP, et al. (2003) Identification or CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii. Infect Immun 71: 3920-3926.
8. Salerno-Goncalves R, Fernandez-Vina M, Lewinsohn DM, Sztein MB (2004) Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 173: 5852-5862.
9. Choi C, Witzens M, Bucur M, Feuerer M, Sommerfeldt N, et al. (2005) Enrichment or functional CD8 memory T cells specific for MUCI in bone marrow of patients with multiple myeloma. Blood 105: 2132-2134.
10. Liblau RS, Wong FS, Mars LT, Santamaria P (2002) Autoreactive CD8 T cells in organ-specific autoimummity: emerging targets for therapeutic intervention. Immunity 17: 1-6.
11. Sette A, Peters B (2007) Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr Opin Immunol 19: 106-110.
12. McMurry JA, Kimball S, Lee JH, Rivera D, Martin W, et al. (2007) Epitope-driven TB vaccine development: a streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice. Curr Mol Med 7: 351-368.
13. Pascolo S (2005) HLA class I transgenic mice: development, utilisation and improvement. Expert Opin Biol Ther 5: 919-938.
14. Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, et al. (2003) An essential role for tripepidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 4: 375-379.
15. Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, et al. (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20: 495-506.
16. Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354.
17. Fruci D, Lauvau G, Saveanu L, Amicosante M, Butler RH, et al. (2003) Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport. J Immunol 170: 2977-2984.
18. Momburg F, Roelse J, Hammerling GJ, Neefjes JJ (1991) Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 179: 1613-1623.
19. Schumacher TN, Kantesaria DV, Heemels MT, Ashton-Rickardt PG, Shepherd JC, et al. (1991) Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 179: 533-540.
20. van Endert PM, Tampe R, Meyer TH, Tisch R, Bach JF, et al. (1994) A sequential model for peptide binding and transport by the transporters associated vith antigen processing. Immunity 1: 491-500.
21. Chang SC, Momburg F, Bhutani N, Goldberg AL (2005) The ER aminopeptidase, ERAP1, trims precursors to lengths of MEC class I peptides by a "molecular ruler" mechanism. Proc Natl Arad Sci U S A 102: 17107-17112.
22. Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, et al. (2005) Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in die endoplasmic reticulum. Nat Immunol 6: 689-697.
23. Higgins CF (1992) ABC transporters: from microorganism to man. AnnuRevCell Biol 8: 67-113.
24. van Endert PM, Saveanu L, Hewitt EW, Lehner P (2002) Powering the peptide pump: TAP crosstalk with energetic nucleotides. Trends Biochem Sci 27: 454-461.
25. Neefjes JJ, Momburg F, Hammerling GJ (1993) Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261: 769-771.
26. Koopmann JO, Albring J, Huter E, Bulbuc N, Spee P, et al. (2000) Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 13: 117-127.
27. Roelse J, Gromme M, Momburg F, Hammerling G, Neefjes J (1994) Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 180: 1591-1597.
28. Herberts CA, Neijssen JJ, de Haan J, Janssen L, Drijfhout JW, et al. (2006) Cutting edge: HLA-B27 acquires many N-terminal dibasic pepitides: coupling cytosolic peptide stability to antigen presentation. J Immunol 176: 2697-2701.
29. Gromme M, van der Valk R, Sliedregt K, Vernie L, Liskamp R, et al. (1997) The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics. Eur J Immunol 27: 898-904.
30. Gubler B, Daniel S, Armandola EA, Hammer J, Caillat-Zucman S, et al. (1998) Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP. Mol Immunol 35: 427-433.
31. van Endert PM, Riganelli D, Greco G, Fleischhauer K, Sidney J, et al. (1995) The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 182: 1883-1895.
32. Peters B, Bulik S, Tampe R, Van Endert PM, Holzhutter HG (2003) Identifying NTHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol 171: 1741-1749.
33. Heemels MT, Schumacher TN, Wonigeit K, Ploegh HL (1993) Peptide translocation by variants of the transporter associated with antigen processing. Science 262: 2059-2063.
34. Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, et al. (1994) Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367: 648-651.
35. Heemels MT, Ploegh HL (1994) Substrate specificity of allelic variants of the TAP peptide transporter. Immunity 1: 775-784.
36. Neefjes J, Gottfried E, Roelse J, Gromme M, Obst R, et al. (1995) Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur J Immunol 25: 1133-1136.
37. Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, et al. (1998) Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J Immunol 161: 617-624.
38. Uebel S, Kraas W, Kienle S, Wiesmuller KH, Jung G, et al. (1997) Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries. Proc Natl Acad Sci U S A 94: 8976-8981.
39. Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, et al. (2003) Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 62: 378-384.
40. Udaka K, Mamitsuka H, Nakaseko Y, Abe N (2002) Empirical evaluation of a dynamic experiment design method for prediction of MHC class I-binding peptides. J Immunol 169: 5744-5753.
41. Momburg F, Neefjes JJ, Hammerling GJ (1994) Peptide selection by MHC-encoded TAP transporters. Curr Opin Immunol 6: 32-37.
42. Kotturi MF, Peters B, Buendia-Laysa F Jr., Sidney J, Oseroff C, et al. (2007) The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J Virol 81: 4928-4940.
43. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, et al. (2006) A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24: 817-819.
44. Peh CA, Laham N, Burrows SR, Zhu Y, McCluskey J (2000) Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading. J Immunol 164: 292-299.
45. Lauvau G, Glaichenhaus N (2004) Mini-review: Presentation of pathogen-derived antigens in vivo. Eur J Immunol 34: 913-920.
46. Peters B, Sette A (2005) Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6: 132.
47. Sidney J, Peters B, Moore C, Pencille TJ, Ngo S, et al. (2007) Characterization of the peptide-binding specificity of the chimpanzee class I alleles A 0301 and A 0401 using a combinatorial peptide library. Immunogenetics 59: 745-751.